Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 4
2005 3
2006 2
2008 2
2012 2
2013 3
2014 1
2015 2
2016 3
2017 2
2018 3
2019 8
2020 1
2021 6
2022 12
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study.
Breznik JA, Rahim A, Bhakta H, Clare R, Zhang A, Ang J, Stacey HD, Liu LM, Kennedy A, Bilaver L, Hagerman M, Kajaks T, Bramson JL, Nazy I, Miller MS, Costa AP, Bowdish DME; COVID in LTC Investigator Group. Breznik JA, et al. Among authors: zhang a. J Med Virol. 2023 Oct;95(10):e29170. doi: 10.1002/jmv.29170. J Med Virol. 2023. PMID: 37822054
Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities.
Breznik JA, Rahim A, Zhang A, Ang J, Stacey HD, Bhakta H, Clare R, Liu LM, Kennedy A, Hagerman M, Kajaks T, Miller MS, Nazy I, Bramson JL, Costa AP, Bowdish DME. Breznik JA, et al. Among authors: zhang a. EClinicalMedicine. 2023 Aug 21;63:102148. doi: 10.1016/j.eclinm.2023.102148. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37753447 Free PMC article.
Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogens.
Rashu R, Ninkov M, Wardell CM, Benoit JM, Wang NI, Meilleur CE, D'Agostino MR, Zhang A, Feng E, Saeedian N, Bell GI, Vahedi F, Hess DA, Barr SD, Troyer RM, Kang CY, Ashkar AA, Miller MS, Haeryfar SMM. Rashu R, et al. Among authors: zhang a. PLoS Pathog. 2023 Jun 29;19(6):e1011485. doi: 10.1371/journal.ppat.1011485. eCollection 2023 Jun. PLoS Pathog. 2023. PMID: 37384813 Free PMC article.
Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada.
Jacob RA, Zhang A, Ajoge HO, D'Agostino MR, Nirmalarajah K, Shigayeva A, Demian WL, Baker SJC, Derakhshani H, Rossi L, Nasir JA, Panousis EM, Draia AN, Vermeiren C, Gilchrist J, Smieja N, Bulir D, Smieja M, Surette MG, McArthur AG, McGeer AJ, Mubareka S, Banerjee A, Miller MS, Mossman K. Jacob RA, et al. Among authors: zhang a. Emerg Infect Dis. 2023 Jul;29(7):1386-1396. doi: 10.3201/eid2907.230198. Epub 2023 Jun 12. Emerg Infect Dis. 2023. PMID: 37308158 Free PMC article.
Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study.
Leong DP, Zhang A, Breznik JA, Clare R, Huynh A, Mushtaha M, Rangarajan S, Stacey H, Kim PY, Loeb M, Denburg JA, Mertz D, Chagla Z, Nazy I, Miller MS, Bowdish DME, Duong M. Leong DP, et al. Among authors: zhang a. PLoS One. 2023 Feb 15;18(2):e0281673. doi: 10.1371/journal.pone.0281673. eCollection 2023. PLoS One. 2023. PMID: 36791069 Free PMC article.
65 results